Californian ballot gives public "direct voice" in drug cost debate Comment 05 November 2016 Pages: 1 - 1
Denosumab not cost effective for osteoporosis in Australia Clinical study 05 November 2016 Pages: 13 - 13
DPP-4 inhibitors cost effective for second-line T2DM treatment Clinical study 05 November 2016 Pages: 14 - 14
Economic benefits with high-dose IIV3 in elderly US patients Clinical study 05 November 2016 Pages: 15 - 15
Empiric treatment proposed for high-risk suspected paediatric TB Clinical study 05 November 2016 Pages: 16 - 16
Expansion of TB services cost effective in high-burden countries Clinical study 05 November 2016 Pages: 18 - 18
Free national influenza vaccination program costly in China Clinical study 05 November 2016 Pages: 19 - 19
Historical data common in economic models without RCTs Clinical study 05 November 2016 Pages: 21 - 21
Insulin analogues cost effective for T1DM, uncertain for T2DM Clinical study 05 November 2016 Pages: 22 - 22
Less frequent cervical cancer screening cost effective Clinical study 05 November 2016 Pages: 23 - 23
Lower PNP costs with pregabalin vs gabapentin in Spain Clinical study 05 November 2016 Pages: 24 - 24
Medicare subsidy improves persistence with hormonal therapy Clinical study 05 November 2016 Pages: 25 - 25
Sevelamer cost effective for ESRD hyperphosphatemia in China Clinical study 05 November 2016 Pages: 27 - 27
Sorafenib not cost effective for HCC with decompensation Clinical study 05 November 2016 Pages: 29 - 29
Substantial economic burden from unvaccinated adults in US Clinical study 05 November 2016 Pages: 30 - 30
Systematic PSA screening not cost effective in Australia Clinical study 05 November 2016 Pages: 31 - 31
Cost of devices to be reduced for private patients in Australia Media release 05 November 2016 Pages: 33 - 33
UK NICE recommends genetic testing for colorectal cancer pts News item 05 November 2016 Pages: 36 - 36